Thursday, August 6

Browsing: CAMP4

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

By healthylife7August 6, 20260

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

What's Hot

Martha Stewart Leaves Meghan Markle ‘Shaken’ With Lifestyle Brand Criticism, According to Sources

Michigan eases lettuce advice as state health department says cyclosporiasis reports decline

Marine recruit dies during fitness test at USMC Base Camp Pendleton

Browsing: CAMP4

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

Martha Stewart Leaves Meghan Markle ‘Shaken’ With Lifestyle Brand Criticism, According to Sources

Michigan eases lettuce advice as state health department says cyclosporiasis reports decline

Marine recruit dies during fitness test at USMC Base Camp Pendleton

Can Eating Less Protein Help You Live Longer? Studies Offer Clues

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Martha Stewart Leaves Meghan Markle ‘Shaken’ With Lifestyle Brand Criticism, According to Sources

Michigan eases lettuce advice as state health department says cyclosporiasis reports decline

Marine recruit dies during fitness test at USMC Base Camp Pendleton

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: CAMP4